Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, August 29, 2007

Phase Forward lands N.C.-based CRO as client

Waltham-based Phase Forward Inc. reports that a global contract research firm based in North Carolina will use its information technology designed for clinical trials.

AAIPharma Inc., of Wilmington, N.C., has selected Phase Forward's "Inform" electronic data capture system and its "Clintrial" clinical trial management software, according to AAIPharma, which operates sites throughout the United States, Canada, Europe and South America.

Financial details of the deal were not disclosed.

Phase Forward said its products and services have been used in more than 10,000 clinical trials that have involved more than 1 million patients and 250 organizations. With 450 employees, the firm reported 2006 net income of $12.4 million on revenue of $106.6 million.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Bill Gates, Ray Ozzie, Microsoft execs patent 'personal data mining'

By Todd Bishop TechFlash Bill Gates, Ray Ozzie and a bunch of other heavy-hitters from Microsoft are named as inventors on a newly issued patent for a "personal data mining" system that would analyze information and make recommendations with the goal of aiding a person's decisions and improving quality of life. The patent was issued this week, based on a September 2006 patent application. I...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio